Format

Send to

Choose Destination
Int J Clin Oncol. 2019 Jun 15. doi: 10.1007/s10147-019-01485-z. [Epub ahead of print]

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Author information

1
Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan. yhashi@med.teikyo-u.ac.jp.
2
Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
3
Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
4
Department of Radiation Oncology, Showa University School of Medicine, Tokyo, Japan.
5
Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
6
Department of Gastroenterological Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
7
Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
8
Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
9
Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
10
Department of Chemotherapy and Oncosurgery, Tokyo Medical and Dental University Medical Hospital, Tokyo, Japan.
11
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
12
Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.
13
Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
14
Department of Radiation Oncology, faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
15
Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
16
Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.
17
Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
18
Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
19
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Aichi, Japan.
20
Department of Surgery, National Defense Medical College, Saitama, Japan.
21
Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.
22
Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
23
Department of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, School of Medicine, International University of Health and Welfare, Narita, Japan.
24
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
25
Center for Data Science, Yokohama City University, Yokohama, Japan.
26
Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.
27
Division of Clinical Oncology, Kochi Health Sciences Center, Kochi, Japan.
28
Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
29
Department of Specialized Surgeries, Tokyo Medical and Dental University, Tokyo, Japan.
30
Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, Japan.
31
Library of SEIREI, SAKURA Citizen Hospital, Sakura, Japan.
32
Department of Surgery, Mizonokuchi Hospital, Teikyo University School of Medicine, Kanagawa, Japan.
33
Department of Surgery, Sano City Hospital, Tochigi, Japan.
34
Tokyo Medical and Dental University, Tokyo, Japan.

Abstract

The number of deaths from colorectal cancer in Japan continues to increase. Colorectal cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of treatments was performed, with corrections and additions made based on knowledge acquired since the 2016 version (drug therapy) and the 2014 version (other treatments). The Japanese Society for Cancer of the Colon and Rectum guidelines 2019 for the treatment of colorectal cancer (JSCCR guidelines 2019) have been prepared to show standard treatment strategies for colorectal cancer, to eliminate disparities among institutions in terms of treatment, to eliminate unnecessary treatment and insufficient treatment and to deepen mutual understanding between healthcare professionals and patients by making these guidelines available to the general public. These guidelines have been prepared by consensuses reached by the JSCCR Guideline Committee, based on a careful review of the evidence retrieved by literature searches and in view of the medical health insurance system and actual clinical practice settings in Japan. Therefore, these guidelines can be used as a tool for treating colorectal cancer in actual clinical practice settings. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. Controversial issues were selected as clinical questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here, we present the English version of the JSCCR guidelines 2019.

KEYWORDS:

Chemotherapy; Colorectal cancer; Endoscopy; Guideline; Radiotherapy; Surgery

PMID:
31203527
DOI:
10.1007/s10147-019-01485-z

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center